Skip to content

Thursday, November 12, 2026

Top Stories Global Economy Markets Topics & Series Contributors Opinion

All desks ⌄

Economy & Finance

Economy Investing Central Banks Digital Currency Fintech Research & Analysis Technicals

Power & Business

Politics Business Law Insights & Views Governance Market Roundups

Science & Society

Technology Science Nature Health Life

In focus · trending topic

MaxCyte

1 stories · following the connections

A technician handles sealed reagent bottles in a cleanroom in Sarasota, Florida (AI-generated image / EconoTimes)

MaxCyte Agrees to Buy Akron Bio in $151.8 Million Cell-Therapy Deal

By Helena WardNov 12, 2026, 2:10 AM UTC

←1→Page 1 of 1

Connected markets

Follow the indicators behind the story.

Illustrative data · 06 Oct 2026, 08:00 UTC

Keep exploring

Biotechnology Nigeria Cell therapy Mergers and acquisitions Bola Tinubu Peter Obi Akron Bio

Coverage

Global Economy Markets Technology Politics All news

Intelligence

Topics & Series Contributors Research

Company

About us Become a contributor Contact [email protected]Editorial standards

© 2026 Econometrics LLC. 21 Penn Plaza New York, NY United States 10001Privacy Terms of use Our standards

Home Markets Topics Search